Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that injecting engineered dendritic cells directly into cancerous lung tumors can help promote a stronger immune response, causing more T cells to become active and attack the cancer more effectively.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup